114 related articles for article (PubMed ID: 17602066)
1. Questions about the role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer.
Haines IE
J Clin Oncol; 2007 Jul; 25(19):e24-5. PubMed ID: 17602066
[No Abstract] [Full Text] [Related]
2. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Zalcberg J; Cesano A; Gayko U; Chen MG; Clarke S
J Clin Oncol; 2006 Nov; 24(33):5194-200. PubMed ID: 17075109
[TBL] [Abstract][Full Text] [Related]
3. Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer.
Zalcberg JR; Rosen LS; Abdi E; Davis ID; Gutheil J; Schnell FM; Cesano A; Gayko U; Chen MG; Clarke S
J Clin Oncol; 2008 Mar; 26(8):1386-7. PubMed ID: 18323563
[No Abstract] [Full Text] [Related]
4. Whose opinion counts?
Loprinzi CL; Barton DL; Sloan JA
J Clin Oncol; 2006 Nov; 24(33):5183-5. PubMed ID: 17075108
[No Abstract] [Full Text] [Related]
5. Summaries for patients. Palifermin can prevent severe oral mucositis during chemotherapy.
Ann Intern Med; 2010 Sep; 153(6):I-44. PubMed ID: 20855786
[No Abstract] [Full Text] [Related]
6. OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy.
Rosa DD; Ismael GF; de Azambuja E; Braga S; Cardoso F; Bleiberg H
J Clin Oncol; 2006 Nov; 24(32):5176-7; author reply 5177. PubMed ID: 17093286
[No Abstract] [Full Text] [Related]
7. Palifermin: new drug. Prevention of oral mucositis: inappropriate evaluation.
Prescrire Int; 2007 Aug; 16(90):135-8. PubMed ID: 17724832
[TBL] [Abstract][Full Text] [Related]
8. Palifermin and chemotherapy-induced oral mucositis.
Köstler WJ; Hejna M; Zielinski CC
N Engl J Med; 2005 Mar; 352(12):1264-5; author reply 1264-5. PubMed ID: 15791702
[No Abstract] [Full Text] [Related]
9. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
11. Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice.
Dörr W; Bässler S; Reichel S; Spekl K
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):881-7. PubMed ID: 15936573
[TBL] [Abstract][Full Text] [Related]
12. Palifermin in prevention of head and neck cancer radiation-induced mucositis: not yet a definitive word on safety and efficacy profile.
Bossi P; Locati LD; Licitra L
J Clin Oncol; 2012 Feb; 30(5):564-5; 565-567. PubMed ID: 22215750
[No Abstract] [Full Text] [Related]
13. Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?
Sonis ST
Nat Clin Pract Oncol; 2005 Mar; 2(3):134-5. PubMed ID: 16264905
[No Abstract] [Full Text] [Related]
14. Palifermin dose should be adjusted to different therapy regimens.
Verhagen MP; Wondergem MJ; Visser O
Bone Marrow Transplant; 2009 Apr; 43(8):665. PubMed ID: 19029966
[No Abstract] [Full Text] [Related]
15. Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy.
Baydar M; Dikilitas M; Sevinc A; Aydogdu I
J Natl Med Assoc; 2005 Aug; 97(8):1161-4. PubMed ID: 16173332
[TBL] [Abstract][Full Text] [Related]
16. FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature.
Berretta M; Di Benedetto F; Bearz A; Simonelli C; Martellotta F; Del Ben C; Berretta S; Spina M; Tirelli U
Cancer Invest; 2008 Jul; 26(6):610-4. PubMed ID: 18584352
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer.
Punt CJ; Koopman M
J Clin Oncol; 2008 Apr; 26(11):1907-8; author reply 1908-9. PubMed ID: 18398161
[No Abstract] [Full Text] [Related]
18. Metastatic colorectal cancer: is surgery necessary?
Schmidt C
J Natl Cancer Inst; 2009 Aug; 101(16):1113-5. PubMed ID: 19671774
[No Abstract] [Full Text] [Related]
19. [Prevention of stomatitis induced by anti-cancer drugs].
Dozono H; Nakamura K; Motoya T; Nakamura S; Shinmura R; Miwa K; Ishibashi M; Nagata Y
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3449-51. PubMed ID: 2679397
[TBL] [Abstract][Full Text] [Related]
20. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
